Submission for OMB Review; 30-Day Comment Request; Food and Drug Administration (FDA) and the National Cancer Institute (NCI) Health Communication Survey (FDA-NCI), 7483-7484 [2015-02691]
Download as PDF
<![CDATA[
7483
Federal Register / Vol. 80, No. 27 / Tuesday, February 10, 2015 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Regulation citation
§ 60.21: How to dispute
the accuracy of NPDB
information.
Administrative ...................
Total ...........................
Self-Query on an Organization.
Continuous Query (manual).
Continuous Query (automated).
Subject Statement and
Dispute.
Request for Dispute Resolution.
Non-Hospital Entity Registration (Initial).
Non-Hospital Entity Registration (Renewal).
Hospital Registration (Initial).
Hospital Registration (Renewal).
Licensing Board Data Request.
Reporting Entity Discrepancy Letter.
Licensing Board Attestation.
Corrective Action Plan ......
Reconciling Missing Actions.
Agent Registration (Initial)
Agent Registration (Renewal).
Electronic Transfer of
Funds (EFT) Authorization.
Authorized Agent Designation.
Account Discrepancy ........
...........................................
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–02658 Filed 2–9–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Food and Drug
Administration (FDA) and the National
Cancer Institute (NCI) Health
Communication Survey (FDA–NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
rljohnson on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
Number of
respondents
Form name
15:20 Feb 09, 2015
Jkt 235001
Responses
per
respondent
Frm 00082
Total burden
hours
427
1
427
508,203
1
508,203
.08
121,718
1
121,718
.0003
3,501
1
3,501
94
1
94
8
752
524
1
524
1
524
6,383
1
6,383
37
1
37
3,198
1
3,198
140
1
140
10.5
1,470
389
1
389
4
1556
354
1
354
1
354
10
2,176
1
1
10
2,176
.08
0.8
1
174
30
194
1
1
30
194
1
427
566
1
788
.75
.25
40,656
37
2,626
1,596
1
37
.25
800
.08
30
16
566
.08
45
1
788
.25
197
41
1
41
.25
10
5,009,324
........................
5,009,324
the Federal Register on December 4,
2014 (Vol. 79, No. 233, pages 72003–4)
and allowed 60 days for public
comment. A total of five public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
PO 00000
Average burden
per response
(in hours)
Total
responses
Fmt 4703
Sfmt 4703
1
..........................
275,689
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Bradford W. Hesse, Ph.D.,
Health Communication and Informatics
Research Branch, 9609 Medical Center
Drive, MSC 9761, Room 3E610,
Rockville, MD 20850 or call non-toll
free number 240–276–6721 or Email
your request, including your address, to
hesseb@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Proposed Collection: Health
Information National Trends Survey
(HINTS) 0925–0538, Reinstatement with
Change, National Cancer Institute (NCI),
National Institutes of Health (NIH).
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\10FEN1.SGM
10FEN1
7484
Federal Register / Vol. 80, No. 27 / Tuesday, February 10, 2015 / Notices
Need and Use of Information
Collection: This partnership between
NCI and FDA will include assessing the
public’s knowledge of medical devices,
communications related to product
recalls, nutritional supplement labeling,
and topics to inform FDA’s regulatory
authority over tobacco, such as such as
risk perceptions about new tobacco
products, product pack color gradations,
comprehensive assessment of the
American public’s current access to, and
use of, information about cancer across
the cancer care continuum from cancer
prevention, early detection, diagnosis,
treatment, and survivorship.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 2,159.
perceptions of product harm, and
tobacco product claims and labels. This
HINTS survey will couple knowledgerelated questions with inquiries into the
communication channels through which
understanding is being obtained, and
assessment of FDA-regulated material.
This survey will extend the information
collected and priorities from HINTS
which have been to provide a
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Individuals ........................................................................................................
4,318
1
30/60
2,159
Dated: February 4, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2015–02691 Filed 2–9–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on April
8–9, 2015. The topic for this meeting
will be ‘‘Opportunities for Research
Supported by the Special Statutory
Funding Program for Type 1 Diabetes
Research.’’ The meeting is open to the
public.
DATES: The meeting will be held on
April 8, 2015 from 8:00 a.m. to 5:45 p.m.
and on April 9, 2015 from 8:00 a.m. to
4:45 p.m.
ADDRESSES: The meeting will be held at
the NIH Neuroscience Center,
Conference Room C (April 8) and
Conference Room A1/A2 (April 9), 6001
Executive Boulevard, Rockville, MD
20852. Non-federal individuals
planning to attend the workshop should
register by email to Denise Hoffman,
The Scientific Consulting Group, Inc.
(dhoffman@scgcorp.com; please put
‘‘Registration DMICC T1D Meeting’’ in
the subject line) at least 7 days prior to
the workshop.
FOR FURTHER INFORMATION CONTACT: An
agenda for the DMICC meeting will be
available by contacting Denise Hoffman,
The Scientific Consulting Group, Inc.
(dhoffman@scgcorp.com; please put
‘‘Agenda Request for DMICC T1D
Meeting’’ in the subject line). For further
rljohnson on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:57 Feb 09, 2015
Jkt 235001
information concerning this meeting,
contact Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
April 8–9, 2015 DMICC meeting will
focus on ‘‘Opportunities for Research
Supported by the Special Statutory
Funding Program for Type 1 Diabetes
Research.’’
Any interested person may file
written comments with the Committee
by forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, there will not be time on the
agenda for oral comments from
members of the public.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Date: February 4, 2015.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2015–02693 Filed 2–9–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
project: Center for Integrative Biomedical
Computing.
Date: February 17–19, 2015.
Time: 7:00 p.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Salt Lake City, 150 West
500 South, Salt Lake, UT 84101.
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for Scentific
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 80, Number 27 (Tuesday, February 10, 2015)]
[Notices]
[Pages 7483-7484]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Food and Drug
Administration (FDA) and the National Cancer Institute (NCI) Health
Communication Survey (FDA-NCI)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH), has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on December 4, 2014 (Vol. 79, No. 233, pages 72003-4) and
allowed 60 days for public comment. A total of five public comments
were received. The purpose of this notice is to allow an additional 30
days for public comment. The National Cancer Institute (NCI), National
Institutes of Health, may not conduct or sponsor, and the respondent is
not required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project contact: Bradford W. Hesse, Ph.D., Health
Communication and Informatics Research Branch, 9609 Medical Center
Drive, MSC 9761, Room 3E610, Rockville, MD 20850 or call non-toll free
number 240-276-6721 or Email your request, including your address, to
hesseb@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Proposed Collection: Health Information National Trends Survey
(HINTS) 0925-0538, Reinstatement with Change, National Cancer Institute
(NCI), National Institutes of Health (NIH).
[[Page 7484]]
Need and Use of Information Collection: This partnership between
NCI and FDA will include assessing the public's knowledge of medical
devices, communications related to product recalls, nutritional
supplement labeling, and topics to inform FDA's regulatory authority
over tobacco, such as such as risk perceptions about new tobacco
products, product pack color gradations, perceptions of product harm,
and tobacco product claims and labels. This HINTS survey will couple
knowledge-related questions with inquiries into the communication
channels through which understanding is being obtained, and assessment
of FDA-regulated material. This survey will extend the information
collected and priorities from HINTS which have been to provide a
comprehensive assessment of the American public's current access to,
and use of, information about cancer across the cancer care continuum
from cancer prevention, early detection, diagnosis, treatment, and
survivorship.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,159.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Individuals................................. 4,318 1 30/60 2,159
----------------------------------------------------------------------------------------------------------------
Dated: February 4, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2015-02691 Filed 2-9-15; 8:45 am]
BILLING CODE 4140-01-P
